Wed, Dec 24, 2014, 10:43 PM EST - U.S. Markets closed early today


% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • robert.scozzafava robert.scozzafava May 13, 2013 8:07 PM Flag

    2 good up i am shocked....I am only 50% down now.....

    what's with all the wall street analysts who were saying $30 - $35 a share? were they smoking too much dope?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Shhhhhh.... don't tell anybody, but I'm in @ $12.24.........BWAHAHAHAHAHAHAHAHAHA!!!! HEHEHEHE!!! lol

    • Geeze!! I thought I was the big loser at 40% down. I guess we have to hang in there for another year or so.

      Sentiment: Hold

    • Absolutely, agree with you. Nothing wrong with company, it's management and the product (Vascepa) itself. I believe, Management is doing a decent job so far. Disclosure, I am long this stock and still believe this company will be acquired sooner or later. But these analysts, I think jumped guns and made such bad calls last year. I would say, only Akiva Felt (Wedbush) made a reasonable call,at the right time. All the other analysts (price targets , Ritu Baral - $28, Aegis Capital - $35, JPM $19, Citi - $21, Leerink Swann -$26, MKM Partners $22 and a bunch of other analysts had price targets above $20). Lesson learned the hard way - When every analyst on WallStreet is bullish a certain stock, you absolutely gotta stay away from that stock. I have seen this time and again. I don't believe there was one analyst who was bearish AMRN around June-October 2012.
      It was a high risk/reward investment at that time. If Vascepa had received NCE decision last year (before November) , we probably would not be talking about this now. It just a bad luck for AMRN investors who were hoping for a quick buyout.

      Sentiment: Strong Buy

0.9916-0.0021(-0.21%)Dec 24 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.